Fig. 4. Binding activities of the isolated nanobody candidates.
(A) SDS-PAGE analysis of the purified recombinant nanobody candidates. (B) ELISA of nanobody candidates. Anti-PD-1, anti-ATXN1, and anti-STAT3 nanobodies were examined with their target. Means ± S.D. were shown. Each experiment was repeated over three times independently. PD-1, programmed cell death protein 1; ATXN1, ataxin 1; STAT3, signal transducer and activator of transcription 3.
© Korean J Physiol Pharmacol
